Effexor and Uptravi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Uptravi (selexipag). Common drug interactions include nasal congestion among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Uptravi. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Uptravi?

Uptravi has active ingredients of selexipag. eHealthMe is studying from 26,576 Uptravi users. Check the latest studies of Uptravi.



On Aug, 03, 2026

40 people who take Effexor and Uptravi together, and have interactions are studied.

Effexor and Uptravi drug interactions.

What are the common drug interactions of Effexor and Uptravi, by gender? *:

female:

  1. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  2. Wheezing (a high-pitched whistling sound made while you breath)
  3. Back pain
  4. Dehydration (dryness resulting from the removal of water)
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Hospitalisation
  7. Pyrexia (fever)
  8. Haematochezia (passage of stools containing blood)
  9. Gastrointestinal motility disorder (abnormal intestinal contractions)
  10. Heart rate increased

male:

  1. Headache (pain in head)
  2. Pulmonary hypertension (increase in blood pressure in the lung artery)
  3. Back pain
  4. Blood creatinine increased
  5. Brain abscess
  6. Chest pain
  7. Electric shock
  8. Erythema (redness of the skin)
  9. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  10. Gout (uric acid crystals building up in the body)

What are the common drug interactions of Effexor and Uptravi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Diarrhoea
  2. Headache (pain in head)
  3. Pain in jaw
  4. Arthralgia (joint pain)
  5. Myalgia (muscle pain)
  6. Nausea (feeling of having an urge to vomit)
  7. Pulmonary embolism (blockage of the main artery of the lung)
  8. Vomiting
  9. Abdominal distension
  10. Ascites (accumulation of fluid in the abdominal cavity)

50-59:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Presyncope
  3. Abdominal discomfort
  4. Blood glucose increased
  5. Fluid overload (too much fluid in the blood)
  6. Hyperhidrosis (abnormally increased sweating)
  7. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  8. Rash pruritic (redness with itching)
  9. Bone pain
  10. Haemoglobin decreased

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Dehydration (dryness resulting from the removal of water)
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Fatigue (feeling of tiredness)
  5. Muscular weakness (muscle weakness)
  6. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  7. Pain
  8. Pain in jaw
  9. Wheezing (a high-pitched whistling sound made while you breath)
  10. Dizziness

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 33 people, 82.50%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 17.50%
  3. Pain: 4 people, 10.00%
  4. Autoimmune Hepatitis: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Uptravi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Uptravi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uptravi:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uptravi and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and selexipag (the active ingredients of Effexor and Uptravi, respectively), and Effexor and Uptravi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: